Evidence map›Paper›PMID 28700033›Full record

ArticleBrazilian journal of medical and biological research = Revista brasileira de pesquisas medicas e biologica2017

Astragalus polysaccharides improve cardiomyopathy in STZ-induced diabetic mice and heterozygous (SOD2+/-) knockout mice.

J Ju, W Chen, Y Lai, L Wang, H Wang, W J Chen, X Zhao, H Ye, Y Li, Y Zhang

Open access · goldAbstract read
In one paragraph

Article in Brazilian journal of medical and biological research = Revista brasileira de pesquisas medicas e biologica, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
1.2field-weighted citation impact, top 18% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 12 citations in OpenAlex.

  1. Review
  2. Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Diabetes, metabolic syndrome and obesity : targets and therapy · 2018
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 3 institutions in 1 country.

J JuDepartment of Geriatrics, Huashan Hospital, Fudan University, Shanghai, China.
W ChenDepartment of Geriatrics, Huashan Hospital, Fudan University, Shanghai, China.
Y LaiDepartment of Endocrinology, Huashan Hospital, Fudan University, Shanghai, China.
L WangCore Center of Clinical Skill Training, Shanghai Medical College, Fudan University, Shanghai, China.
H WangExperimental Center of Basic Medicine, Shanghai Medical College, Fudan University, Shanghai, China.
W J ChenDepartment of Geriatrics, Huashan Hospital, Fudan University, Shanghai, China.
X ZhaoDepartment of Geriatrics, Huashan Hospital, Fudan University, Shanghai, China.
H YeDepartment of Endocrinology, Huashan Hospital, Fudan University, Shanghai, China.
Y LiDepartment of Endocrinology, Huashan Hospital, Fudan University, Shanghai, China.
Y ZhangDepartment of Geriatrics, Huashan Hospital, Fudan University, Shanghai, China.
Huashan Hospital · CNFudan University · CNShanghai Medical College of Fudan University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Oxidative stress plays an important role in the development of diabetic cardiomyopathy. In the present study, we determined whether the effect of astragalus polysaccharides (APS) on diabetic cardiomyopathy was associated with its impact on oxidative stress. Streptozotocin (STZ)-induced diabetic mice and heterozygous superoxide dismutase (SOD2+/-) knockout mice were administered APS. The hemodynamics, cardiac ultrastructure, and the apoptosis, necrosis and proliferation of cardiomyocytes were assessed to evaluate the effect of APS on diabetic and oxidative cardiomyopathy. Furthermore, H2O2 formation, oxidative stress/damage, and SOD activity in cardiomyocytes were evaluated to determine the effects of APS on cardiac oxidative stress. APS therapy improved hemodynamics and myocardial ultrastructure with reduced apoptosis/necrosis, and enhanced proliferation in cardiomyocytes from both STZ-induced diabetic mice and heterozygous SOD2+/- knockout mice. In addition, APS therapy reduced H2O2 formation and oxidative stress/damage, and enhanced SOD activity in both groups of mice. Our findings suggest that APS had benefits in diabetic cardiomyopathy, which may be partly associated with its impact on cardiac oxidative stress.

Indexed as

AnimalsApoptosisAstragalus PlantCell ProliferationDiabetes Mellitus, ExperimentalDiabetic CardiomyopathiesMaleMiceMice, Inbred C57BLMice, KnockoutMicroscopy, Electron, TransmissionMyocytes, CardiacOxidative StressPlant ExtractsPolysaccharidesStreptozocinPlant ExtractsPolysaccharidesStreptozocinSuperoxide Dismutase

Identifiers

PMID28700033
PMCPMC5505521
OpenAlexW2724350355

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.